ArticleHuman genomics2025

Comparative outcome and prognostic factor analysis among MDS/AML patients with TP53 mutations, snps, and wild type.

Xiaodi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.